Top Markets
Coin of the day
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Zhejiang AngLiKang Pharmaceutical CO.,LTD.

Zhejiang AngLiKang Pharmaceutical CO.,LTD.

002940
Kedudukan dalam Saham #11260
Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on... Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on the manufacturing and distribution of various pharmaceutical goods. Their operations span the production and sale of active pharmaceutical ingredients (APIs), finished drug formulations, and empty capsules for medical use. The company's existing product line encompasses treatments for a variety of conditions, including anti-infective agents, antihypertensives for blood pressure management, medications for digestive system health, and respiratory preparations. Beyond its current offerings, AngLiKang is also deeply involved in drug research and development. Their R&D efforts are concentrated on creating new therapies, with a particular emphasis on oral cephalosporin antibiotics, as well as treatments for cardiovascular, renal (kidney), and central nervous system diseases. The company was established in 2001 and maintains its headquarters in Shengzhou, China.
Harga Saham
$3.69
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$722.97M
Perubahan (1 hari)
-1.62%
Perubahan (1 tahun)
-46.81%
Negara
CN
Perdagangan Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940)

Kategori

Sejarah dividen untuk Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940)
Zhejiang AngLiKang Pharmaceutical CO.,LTD. (simbol saham: 002940) telah membuat sejumlah 0 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): 0.00
Hasil dividen (TTM): 0
Pembayaran dividen untuk Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (diselaraskan untuk pemecahan saham) Ubah
Tidak cukup data untuk tarikh yang disediakan.
Senarai semua pembayaran dividen
Tahun Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pembayaran dividen untuk syarikat serupa atau pesaing